These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 31831046)

  • 61. Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors.
    Viana da Silva S; Haberl MG; Zhang P; Bethge P; Lemos C; Gonçalves N; Gorlewicz A; Malezieux M; Gonçalves FQ; Grosjean N; Blanchet C; Frick A; Nägerl UV; Cunha RA; Mulle C
    Nat Commun; 2016 Jun; 7():11915. PubMed ID: 27312972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.
    Baglietto-Vargas D; Chen Y; Suh D; Ager RR; Rodriguez-Ortiz CJ; Medeiros R; Myczek K; Green KN; Baram TZ; LaFerla FM
    J Neurochem; 2015 Sep; 134(5):915-26. PubMed ID: 26077803
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.
    Volianskis A; Køstner R; Mølgaard M; Hass S; Jensen MS
    Neurobiol Aging; 2010 Jul; 31(7):1173-87. PubMed ID: 18790549
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer's disease correlates with pathology.
    Rosenberger AF; Rozemuller AJ; van der Flier WM; Scheltens P; van der Vies SM; Hoozemans JJ
    Acta Neuropathol Commun; 2014 Jul; 2():79. PubMed ID: 25027113
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
    Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
    FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.
    Kommaddi RP; Das D; Karunakaran S; Nanguneri S; Bapat D; Ray A; Shaw E; Bennett DA; Nair D; Ravindranath V
    J Neurosci; 2018 Jan; 38(5):1085-1099. PubMed ID: 29246925
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SORLA attenuates EphA4 signaling and amyloid β-induced neurodegeneration.
    Huang TY; Zhao Y; Jiang LL; Li X; Liu Y; Sun Y; Piña-Crespo JC; Zhu B; Masliah E; Willnow TE; Pasquale EB; Xu H
    J Exp Med; 2017 Dec; 214(12):3669-3685. PubMed ID: 29114064
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3.
    Reinders NR; Pao Y; Renner MC; da Silva-Matos CM; Lodder TR; Malinow R; Kessels HW
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6526-E6534. PubMed ID: 27708157
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effects of voluntary running on cerebrovascular morphology and spatial short-term memory in a mouse model of amyloidosis.
    Maliszewska-Cyna E; Vecchio LM; Thomason LAM; Oore JJ; Steinman J; Joo IL; Dorr A; McLaurin J; Sled JG; Stefanovic B; Aubert I
    Neuroimage; 2020 Nov; 222():117269. PubMed ID: 32818618
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling.
    Murai KK; Nguyen LN; Irie F; Yamaguchi Y; Pasquale EB
    Nat Neurosci; 2003 Feb; 6(2):153-60. PubMed ID: 12496762
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer's disease.
    Bevan RJ; Hughes TR; Williams PA; Good MA; Morgan BP; Morgan JE
    Acta Neuropathol Commun; 2020 Dec; 8(1):216. PubMed ID: 33287900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dendritic spine density, morphology, and fibrillar actin content surrounding amyloid-β plaques in a mouse model of amyloid-β deposition.
    Kirkwood CM; Ciuchta J; Ikonomovic MD; Fish KN; Abrahamson EE; Murray PS; Klunk WE; Sweet RA
    J Neuropathol Exp Neurol; 2013 Aug; 72(8):791-800. PubMed ID: 23860033
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reversal of long-term dendritic spine alterations in Alzheimer disease models.
    Smith DL; Pozueta J; Gong B; Arancio O; Shelanski M
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16877-82. PubMed ID: 19805389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
    Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
    BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G; Liu HL; Zhang H; Tong XJ
    Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.
    Dong H; Murphy KM; Meng L; Montalvo-Ortiz J; Zeng Z; Kolber BJ; Zhang S; Muglia LJ; Csernansky JG
    J Alzheimers Dis; 2012; 28(3):579-92. PubMed ID: 22045495
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
    Long Z; Zeng Q; Wang K; Sharma A; He G
    Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antagonizing LINGO-1 reduces activated microglia and alleviates dendritic spine loss in the hippocampus of APP/PS1 transgenic mice.
    Xie YH; Jiang L; Zhang Y; Deng YH; Yang H; He Q; Zhou YN; Zhou CN; Luo YM; Liang X; Wang J; Huang DJ; Zhu L; Tang Y; Chao FL
    Neurosci Lett; 2024 Jan; 820():137612. PubMed ID: 38142924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.